pf-06821497
pfizer
['tps282', 'prostate', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'pfizer']
the design of an ongoing phase 1 trial evaluating the pk, safety &amp; antitumor activity of an ezh2 inhibitor + androgen receptor inhibitor (ari) vs ari alone in pts w/ metastatic castration-resistant #prostatecancer is being presented at asco #gu23 tps282 
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/MU3blmItSZ